Drugs / Chlorohexidine
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1/21 trial | ||||||
| Phase 1/2 | NCT03195582 | Aug 2017 → Aug 2018 | bone resorption disease, prosthesis-related infectious disease | Rambam Health Care Campus | Unknown | No outcome recorded |
| Comparator or background therapy2 trials | ||||||
| Phase 2 | NCT07073092 Background | Jul → Dec 2025 overdue | chemotherapy-induced oral mucositis | Ain Shams University | Not yet recruiting | No outcome recorded |
| Phase 3 | NCT05951647 Comparator | Jul → Oct 2023 | gingivitis | Alexandria University | Unknown | No outcome recorded |
Evidence & citations 4 cited values
Every value below carries the sentence it was read from. 3 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Chlorohexidine | “The aim of this study is to evaluate the healing of peri-implat tissue following surgical uncovering with the adjunctive use of Chlorohexidine (CHX) gel.” NCT03195582 ↗ |
| Known as | CHX | “The aim of this study is to evaluate the healing of peri-implat tissue following surgical uncovering with the adjunctive use of Chlorohexidine (CHX) gel.” NCT03195582 ↗ |
| Known as | Corsodyl | “following implant exposure this group will receive Chlorohexidine 1% gel (Corsodyl®) the gel will be applied on the abutment as well as on the implant internal hex and then a 4...” NCT03195582 ↗ |
| Route | Topical | “the gel will be applied on the abutment as well as on the implant internal hex” NCT03195582 ↗ |